|
|
|
Insider
Information: |
Scibetta James S |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
770,845 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$926,101 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
770,845 |
|
|
Total
Value |
$926,101 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
President |
2017-06-05 |
25,118 |
2011-02-15 |
0 |
Premium* |
|
Nephros Inc |
NEPH |
Director |
2013-08-20 |
64,134 |
2013-05-23 |
0 |
Premium* |
|
Matinas Biopharma Holdings, Inc. |
MTNB |
Director |
2021-06-19 |
649,958 |
|
0 |
Premium* |
|
Aquestive Therapeutics, Inc. |
AQST |
|
2019-08-21 |
31,635 |
2019-08-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MTNB |
Matinas Biopharma Holding... |
Director |
|
2017-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
413,309 |
|
- |
|
AQST |
Aquestive Therapeutics, I... |
|
|
2019-08-21 |
4 |
B |
$3.81 |
$3,429 |
D/D |
900 |
31,635 |
0.01 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
President |
|
2017-06-05 |
4 |
S |
$43.32 |
$85,169 |
D/D |
(1,966) |
25,118 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Director |
|
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,400 |
609,298 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Director |
|
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,600 |
621,158 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Director |
|
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
625,958 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2011-02-15 |
4 |
B |
$7.04 |
$35,200 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
|
2015-09-11 |
4 |
B |
$61.37 |
$306,850 |
D/D |
5,000 |
10,504 |
2.74 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Director |
|
2017-09-07 |
4 |
B |
$1.29 |
$6,450 |
D/D |
5,000 |
418,309 |
2.39 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Director |
|
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,260 |
617,558 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-03-28 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-03-28 |
4 |
AS |
$28.49 |
$284,900 |
D/D |
(10,000) |
5,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-06-28 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-06-28 |
4 |
AS |
$28.05 |
$280,460 |
D/D |
(10,000) |
5,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-09-30 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-09-30 |
4 |
AS |
$46.74 |
$467,400 |
D/D |
(10,000) |
5,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-12-30 |
4 |
OE |
$1.61 |
$16,100 |
D/D |
10,000 |
15,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Chief Financial Officer |
|
2013-12-30 |
4 |
AS |
$55.55 |
$555,500 |
D/D |
(10,000) |
5,000 |
0 |
- |
|
AQST |
Aquestive Therapeutics, I... |
|
|
2019-08-19 |
4 |
B |
$3.77 |
$40,547 |
D/D |
10,761 |
19,425 |
0.01 |
- |
|
AQST |
Aquestive Therapeutics, I... |
|
|
2019-08-20 |
4 |
B |
$3.80 |
$43,001 |
D/D |
11,310 |
30,735 |
0.01 |
- |
|
NEPH |
Nephros Inc |
Director |
|
2013-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,078 |
64,134 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
|
2014-05-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
|
2014-05-08 |
4 |
AS |
$74.27 |
$1,125,681 |
D/D |
(15,000) |
5,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
|
2014-08-08 |
4 |
OE |
$1.61 |
$24,150 |
D/D |
15,000 |
20,000 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
SVP, Chief Financial Officer |
|
2014-08-08 |
4 |
AS |
$99.22 |
$1,494,400 |
D/D |
(15,000) |
5,000 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|